Shares of Clover Health Corp (NASDAQ: CLOV), a provider of Medicare Advantage plans in the United States, soared over 10% on Wednesday, likely buoyed by the company's recent achievement of higher Medicare star ratings from the Centers for Medicare and Medicaid Services (CMS).
According to the news, Clover Health's PPO Medicare Advantage plans received a 4-Star rating for 2025, which will positively impact its payments in 2026. Additionally, the company's HMO Medicare Advantage plan received a 3.5-Star rating. Given that over 95% of Clover Health's Medicare Advantage membership utilizes its PPO plans, the improved ratings could significantly benefit the company's future performance.
The higher star ratings reflect Clover Health's exceptional outcomes across various criteria, including medication adherence, preventive screenings, and chronic disease management. Notably, the company scored an impressive 4.94 out of 5 Stars on the Healthcare Effectiveness Data and Information Set (HEDIS), which measures the effectiveness of plans in delivering quality care.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。